Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.20.2
Segment Disclosures
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Segment Disclosures Segment Disclosures
 
The Company has two reportable segments: EksoHealth (also referred to as the medical devices segment) and EksoWorks (also referred to as the industrial devices segment). The EksoHealth segment designs, engineers, manufactures, and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and sells exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The reportable segments are each managed separately because they serve distinct markets.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
  EksoHealth EksoWorks Total
Three months ended June 30, 2020      
Revenue $ 2,086    $ 178    $ 2,264   
Cost of revenue 860    145    1,005   
Gross profit $ 1,226    $ 33    $ 1,259   
Three months ended June 30, 2019      
Revenue $ 2,848    $ 414    $ 3,262   
Cost of revenue 1,334    368    1,702   
Gross profit $ 1,514    $ 46    $ 1,560   
EksoHealth EksoWorks Total
Six Months Ended June 30, 2020
Revenue $ 3,276    $ 455    $ 3,731   
Cost of revenue 1,477    358    1,835   
Gross profit $ 1,799    $ 97    $ 1,896   
Six Months Ended June 30, 2019
Revenue $ 5,662    $ 1,216    $ 6,878   
Cost of revenue 2,634    1,085    3,719   
Gross profit $ 3,028    $ 131    $ 3,159   


Geographic information for revenue based on location of customers is as follows:
  Three Months Ended June 30, Six Months Ended June 30,
  2020 2019 June 30, 2020 June 30, 2019
United States $ 1,640    $ 2,357    $ 2,888    $ 4,728   
All Other 624    905    843    2,150   
  $ 2,264    $ 3,262    $ 3,731    $ 6,878